Cleantech Solutions International Inc(NASDAQ:CLNT) shares jumped 108.02% to $7.78. The company on May 22 announced that it has become a certified supplier of components to China Petroleum and Chemical Corporation (Sinopec) and China National ...

Northern, WI 04/29/2013 (GDPInsider) - Galena Biopharma Inc. (NASDAQ:GALE) is up 6.77% having opened trading at $2.55. The stock has closed previously at $2.54 and has a range today of $2.54 and $2.74 on volume of 1.79 million.

Galena Biopharma, Inc. (NASDAQ: GALE), formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using RNAi-targeted and ...

Biocare Decliners Stock Watch List: Galena Biopharma, Inc. (NASDAQ:GALE), Affymax, Inc. (NASDAQ:AFFY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), and Endo Health Solutions Inc. (NASDAQ:ENDP) Added to Growing Stock Report's Biocare ...

Galena Biopharma Inc (NASDAQ:GALE) shares decreased 4.46% to $2.57. The company on May 9 reported its financial results for the quarter ended March 31, 2013 and provided a business update.

LAKE OSWEGO, Ore., May 9, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, ...

Among the major movers in the biotechnology sector yesterday were MannKind Corporation (NASDAQ: MNKD), Ariad Pharmaceuticals Inc. (NASDAQ: ARIA), ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), Galena Biopharma Inc. (NASDAQ: GALE), and ...

Galena Biopharma, Inc. (NASDAQ:GALE) a biopharmaceutical company that focuses on developing oncology treatments to address major unmet medical needs to advance cancer care is currently up (+1.44%) on 1,903,022 shares traded.

Galena Biopharma Inc (NASDAQ:GALE) shares increased 11.69% to $2.77. The company on May 1 announced the addition of William L. Ashton to the Company's Board of Directors.

Galena Biopharma Inc (NASDAQ:GALE) shares decreased 1.47% to $2.69. The company on May 9 reported its financial results for the quarter ended March 31, 2013 and provided a business update.